March 18, 2021McKesson launches ScriptPAS, empowering oncology practices to reduce time to therapy while enhancing patient care
March 12, 2021FOTIVDA (tivozanib), FDA Approved for Treatment of Relapsed/Refractory Advanced Renal Cell Carcinoma, Available at Biologics by McKesson